Rapid ASPECTS vs Rapid SDH

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 65/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.
by RapidAI
VS
by RapidAI (formerly iSchemaView)

AI Verdict

Rapid ASPECTS is designed to assist in the assessment of ischemic stroke by providing automated ASPECTS scores for thrombectomy eligibility. In contrast, Rapid SDH focuses on the rapid detection of acute and chronic subdural hematomas to accelerate neurocritical care decisions. While both are AI-powered tools from RapidAI that analyze non-contrast CT scans for neurological conditions, they address distinct pathologies and clinical workflows.

Choose Rapid ASPECTS if…

Choose Rapid ASPECTS if your primary need is to quickly and accurately quantify early ischemic changes in stroke patients using non-contrast CT scans. This tool is ideal for streamlining the decision-making process for thrombectomy eligibility, enhancing diagnostic accuracy, and reducing variability among clinicians.

View Rapid ASPECTS →

Choose Rapid SDH if…

Choose Rapid SDH if your priority is the rapid and highly accurate detection of suspected acute and chronic subdural hematomas from CT scans. This solution is best suited for accelerating critical neurosurgical and trauma care decisions by providing immediate notifications to clinicians, thereby expediting patient management.

View Rapid SDH →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature Rapid ASPECTS Rapid SDH
Pricing Annual subscription model; pricing varies by region, hospital type, modules, and imaging modalities. starts at approximately $12,000 for a single module in the united states. Contact vendor
Deployment Software as a Medical Device (SaMD), delivered via PACS, email, and mobile/web applications (cloud-based). Cloud-based, On-premise
BAA Available Yes AI-estimated Yes AI-estimated
FDA Status Yes AI-estimated Yes AI-estimated
HIPAA Yes AI-estimated Yes AI-estimated

Head-to-Head

AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.

Usability

Rapid SDH

Tool B (Rapid SDH) explicitly states it delivers notifications in under a minute, which is slightly faster than Tool A's (Rapid ASPECTS) 'under 2 minutes' for results delivery. Both integrate with common hospital systems like PACS, email, and mobile apps, but the quicker notification time for critical conditions gives Tool B a slight edge in immediate usability.

Clinical Value

Rapid SDH

While both tools offer significant clinical value, Tool B (Rapid SDH) provides more specific and impressive metrics for its performance, boasting a high positive predictive value (PPV) of 99% with 93% sensitivity and 99% specificity for SDHs >1ml. Tool A (Rapid ASPECTS) mentions a 10% improvement in clinician diagnostic accuracy but lacks a baseline or similarly detailed performance statistics for direct comparison.

Pricing & Value

Rapid ASPECTS

Tool A (Rapid ASPECTS) offers more transparency by providing a starting price of approximately $12,000 for a single module in the United States, even though pricing varies. Tool B (Rapid SDH) requires contacting the vendor for pricing, making it difficult to assess its value without an initial cost estimate.

Enterprise Readiness

Rapid SDH

Both tools are FDA-cleared, HIPAA compliant, and offer BAAs, indicating strong regulatory and security readiness. However, Tool B (Rapid SDH) explicitly supports both cloud-based and on-premise deployment, offering greater flexibility for diverse enterprise IT infrastructures compared to Tool A's primarily cloud-based delivery.

Innovation

Rapid SDH

Both tools utilize AI for automated analysis, which is inherently innovative. However, Tool B (Rapid SDH) is highlighted as 'Part of a comprehensive hemorrhagic and trauma care AI solution (with Rapid ICH and Rapid Hyperdensity),' suggesting a broader, integrated platform strategy for multiple conditions, which points to a more expansive and forward-thinking innovative approach.

Support & Docs

Tie

Both tools are products of RapidAI, a company that provides 24/7/365 customer support via email and phone, with multilingual technical services experts. RapidAI also offers a comprehensive 'Content Hub' with guides, videos, webinars, and a 'Help Center' and 'Documentation'. Given they are from the same vendor, it is reasonable to assume both products benefit from the same robust support and documentation infrastructure.

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature Rapid ASPECTS Rapid SDH
Name Rapid ASPECTS Rapid SDH
Company RapidAI RapidAI (formerly iSchemaView)
Description Rapid ASPECTS provides an automated, standardized ASPECTS score from non-contrast CT scans to quantify early ischemic changes and aid in determining thrombectomy eligibility for stroke patients. Rapid SDH by RapidAI is an FDA-cleared AI module that rapidly detects suspected acute and chronic subdural hematomas on CT scans, delivering notifications in under a minute to accelerate neurocritical care decisions.
Key Functionality Automated ASPECTS score generation for non-contrast CT scans, Visualization of regions of asymmetry and ischemic change, Assists in determining thrombectomy eligibility AI-powered detection of suspected hemispheric acute and chronic subdural hematoma (SDH), Notifications to clinicians in one minute or less, Analyzes non-contrast CT scans
Specialties Emergency Medicine, Neurology, Radiology Emergency Medicine, Neurosurgery, Radiology

Videos

Demos, reviews, and walkthroughs featuring Rapid ASPECTS and Rapid SDH.

Loading videos…
Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

Rapid ASPECTS is designed to provide an automated, standardized ASPECTS score from non-contrast CT scans to quantify early ischemic changes and aid in determining thrombectomy eligibility for stroke patients. Rapid SDH, on the other hand, rapidly detects suspected acute and chronic subdural hematomas on CT scans to accelerate neurocritical care decisions.
Rapid ASPECTS delivers its automated ASPECTS score results in under two minutes. Rapid SDH provides notifications to clinicians regarding suspected acute and chronic subdural hematomas in one minute or less.
Rapid ASPECTS has been shown to improve clinician diagnostic accuracy by 10% and increase reader reliability and reduce intra-reader variability. Rapid SDH offers a high positive predictive value (PPV) of 99%, with 93% sensitivity and 99% specificity for subdural hematomas greater than 1ml.
Rapid SDH is explicitly part of a comprehensive hemorrhagic and trauma care AI solution, which includes Rapid ICH and Rapid Hyperdensity. While Rapid ASPECTS is also from RapidAI, its description focuses on its specific role in ischemic stroke assessment.
AI Tool Finder
AI-powered search. Results may not be comprehensive.